9vHPV Vaccine for papillomavirus infections

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Dec 2019: Trial registered, NCT04199689
  2. 27 Feb 2020: Trial started, NCT04199689

The trials

NCT04199689: Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

State
Under way
Phase
Phase 3
People
6,033 taking part
Started
27 Feb 2020
Primary completion
15 Jan 2027
Arms
9vHPV vaccine
Results
None posted
  1. 16 Dec 2019: Trial registered
  2. 27 Feb 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.